{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,28]],"date-time":"2025-06-28T00:10:07Z","timestamp":1751069407363,"version":"3.41.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.transproceed.2017.09.011","type":"journal-article","created":{"date-parts":[[2017,12,2]],"date-time":"2017-12-02T03:34:29Z","timestamp":1512185669000},"page":"2399-2401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Utility of Tolvaptan in the Perioperative Management of Severe Hyponatremia During Liver Transplantation: A Case Report"],"prefix":"10.1016","volume":"49","author":[{"given":"A.","family":"Parekh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Rajaram","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.M.","family":"Subramanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2017.09.011_bib1","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/hep.510280337","article-title":"Hyponatremia in cirrhosis: from pathogenesis to treatment","volume":"28","author":"Gines","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2017.09.011_bib2","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1053\/gast.2002.37073","article-title":"Transjugular intrahepatic portosystemic shunting versus paracentesis plus albumin for refractory ascites in cirrhosis","volume":"123","author":"Gines","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2017.09.011_bib3","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1055\/s-2006-947293","article-title":"New treatments of hepatorenal syndrome","volume":"26","author":"Arroyo","year":"2006","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.transproceed.2017.09.011_bib4","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1053\/j.gastro.2006.02.017","article-title":"Hyponatremia impairs early posttransplantation outcome in patients with cirrhosis undergoing liver transplantation","volume":"130","author":"Londono","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2017.09.011_bib5","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1002\/hep.22846","article-title":"Impact of pretransplant hyponatremia on outcome following liver transplantation","volume":"49","author":"Yun","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2017.09.011_bib6","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1002\/lt.21154","article-title":"The impact of serum sodium concentration on mortality after liver transplantation: a cohort multicenter study","volume":"13","author":"Dawwas","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2017.09.011_bib7","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1111\/j.1440-1746.2009.06162.x","article-title":"Impact of preoperative serum sodium concentration in living donor liver transplantation","volume":"25","author":"Fukuhara","year":"2010","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.transproceed.2017.09.011_bib8","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1111\/j.1478-3231.2009.01982.x","article-title":"Effect of hyponatraemia on outcomes following orthotopic liver transplantation","volume":"29","author":"Hackworth","year":"2009","journal-title":"Liver Int"},{"key":"10.1016\/j.transproceed.2017.09.011_bib9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1016\/S0022-3565(24)37873-5","article-title":"OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats","volume":"287","author":"Yamamura","year":"1998","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.transproceed.2017.09.011_bib10","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1016\/S0140-6736(08)60695-9","article-title":"Non-peptide arginine-vasopressin antagonists: the vaptans","volume":"371","author":"Decaux","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.transproceed.2017.09.011_bib11","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa065181","article-title":"Tolvaptan, a selective oral vasopressin V2-receptor antagonist, for hyponatremia","volume":"355","author":"Schrier","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2017.09.011_bib12","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jhep.2011.08.020","article-title":"Tolvaptan, an oral vasopressin antagonist, in the treatment of hyponatremia in cirrhosis","volume":"56","author":"Cardenas","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2017.09.011_bib13","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1007\/s00535-010-0240-6","article-title":"A\u00a0multicenter, open-label, dose-ranging study to exploratively evaluate the efficacy, safety, and dose-response of tolvaptan in patients with decompensated liver cirrhosis","volume":"45","author":"Okita","year":"2010","journal-title":"J\u00a0Gastroenterol"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517306620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517306620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T23:41:48Z","timestamp":1751067708000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134517306620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S0041134517306620"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.09.011","relation":{},"ISSN":["0041-1345"],"issn-type":[{"type":"print","value":"0041-1345"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Utility of Tolvaptan in the Perioperative Management of Severe Hyponatremia During Liver Transplantation: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.09.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}